Northpond Ventures is a science-driven venture capital firm founded in 2018, with offices in Cambridge, MA; San Francisco, CA; and Bethesda, MD. The firm focuses on building and supporting breakthrough science and technology-driven businesses to create a significant impact on humanity. Northpond Ventures has been recognized as one of the most active lead biotech investors, leading or co-leading over 60 financings in recent years.

The firm's investment areas include life sciences, biotechnology, diagnostics, digital health, and emerging technologies. Northpond Ventures is deeply engaged in the academic ecosystem, having founded The Laboratory for Bioengineering Research and Innovation at the Wyss Institute at Harvard University and launched the MIT-Northpond Program – Advancing Life Science & Engineering Innovation. Additionally, the firm has established the Northpond Laboratories – Program for Research and Innovation at Stanford Medicine.

These initiatives aim to translate scientific discoveries from the lab to create companies primed for seed-stage funding.